Decheng Capital
Overview
Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence. We are a group of dedicated professionals with complementary expertise to build highly successful companies globally. Founded in 2012, Decheng continues to capitalize on a historic opportunity in the rapid growth of healthcare industry as well as breakthroughs in life science research. With over $2 billion in capital and the support from some of the most prestigious limited partners in the world, Decheng is poised to create value for our investors and entrepreneur partners.
Investment Focus
- Innovative technologies
- Strong market presence
- Experienced management teams
Portfolio Companies
Get the full list of 54,000+ investors
Decheng Capital and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about Decheng Capital
What sectors does Decheng Capital invest in?
Decheng Capital invests in Healthcare, Life Sciences, Medical Devices, Diagnostics, Biotech and Life Science Tools, and is based in Shanghai, Shanghai, China. Decheng Capital is listed as a vc in the ConnectSafely investor database.
What stage does Decheng Capital invest at?
Decheng Capital backs companies at Seed and Early Stage, writing cheques of 2M - 2M.
Which regions does Decheng Capital invest in?
Decheng Capital invests across United States and China.
Who are the partners at Decheng Capital?
Team members listed for Decheng Capital include Hongbo Bao (General Counsel and Chief Operating Officer) and Jessie Qiu (Chief Financial Officer).
What companies has Decheng Capital invested in?
Decheng Capital's portfolio includes Mammoth Biosciences, Cellares Corporation and Grail, Inc..
How do I contact Decheng Capital?
Decheng Capital's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
